---
figid: PMC10993482__40659_2024_490_Fig6_HTML
figtitle: Gal-3, Gal-4 and Gal-8 pathways to EMT in cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10993482
filename: PMC10993482__40659_2024_490_Fig6_HTML.jpg
figlink: /pmc/articles/PMC10993482/figure/F6
number: F6
caption: Gal-3, Gal-4 and Gal-8 pathways to EMT in cancer. (a) Extracellular Gal-3
  promotes cell migration of colon cancer cells in a carbohydrate-dependent manner
  through a EGFR/K-Ras-Raf-ERK pathway. (b) Gal-3 overexpression activates a PI3K/AKT/GSK-3β/β-catenin
  signaling pathway that induces EMT and promotes metastasis in mice, and is uncertain
  whether this effect includes secreted Gal-3. (c) Runx2 overexpression enhances Gal-3
  expression and promotes EMT in hepatocellular carcinoma and lung cancer cells. (d)
  In different cancer cell lines, extracellular Gal-3 interacts with Trop2 in a carbohydrate-dependent
  manner to promote the nuclear translocation of β-catenin, leading to EMT. (e) In
  prostate cancer, extracellular Gal-4 binds to and activates different tyrosine kinase
  receptors that trigger ERK and AKT pathways leading to EMT. (f) Gal-8 overexpression
  promotes partial EMT that stimulates cell proliferation, migration, invasion and
  tumor formation of MDCK cells involving an Integrin/FAK/EGFR pathway and proteasome
  activation through un unknown mechanism
papertitle: 'Galectins in epithelial-mesenchymal transition: roles and mechanisms
  contributing to tissue repair, fibrosis and cancer metastasis'
reftext: Elisa Perez-Moreno, et al. Biol Res. 2024;57(NA).
year: '2024'
doi: 10.1186/s40659-024-00490-5
journal_title: Biological Research
journal_nlm_ta: Biol Res
publisher_name: BioMed Central
keywords: EMT | Galectin | Cancer | Metastasis | Tissue repair | Fibrosis | Epithelial-mesenchymal
  plasticity
automl_pathway: 0.9732822
figid_alias: PMC10993482__F6
figtype: Figure
redirect_from: /figures/PMC10993482__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10993482__40659_2024_490_Fig6_HTML.html
  '@type': Dataset
  description: Gal-3, Gal-4 and Gal-8 pathways to EMT in cancer. (a) Extracellular
    Gal-3 promotes cell migration of colon cancer cells in a carbohydrate-dependent
    manner through a EGFR/K-Ras-Raf-ERK pathway. (b) Gal-3 overexpression activates
    a PI3K/AKT/GSK-3β/β-catenin signaling pathway that induces EMT and promotes metastasis
    in mice, and is uncertain whether this effect includes secreted Gal-3. (c) Runx2
    overexpression enhances Gal-3 expression and promotes EMT in hepatocellular carcinoma
    and lung cancer cells. (d) In different cancer cell lines, extracellular Gal-3
    interacts with Trop2 in a carbohydrate-dependent manner to promote the nuclear
    translocation of β-catenin, leading to EMT. (e) In prostate cancer, extracellular
    Gal-4 binds to and activates different tyrosine kinase receptors that trigger
    ERK and AKT pathways leading to EMT. (f) Gal-8 overexpression promotes partial
    EMT that stimulates cell proliferation, migration, invasion and tumor formation
    of MDCK cells involving an Integrin/FAK/EGFR pathway and proteasome activation
    through un unknown mechanism
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LGALS3
  - EGFR
  - KRAS
  - LGALS8
  - LGALS4
  - ERBB2
  - ERBB3
  - TACSTD2
  - IGF1R
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PDK1
  - PDPK1
  - PTK2
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - CTNNB1
  - ITK
  - SLC22A3
  - RUNX2
  - Lactose
  - MEK
  - RAS
---
